Premium
Janux Therapeutics Inc (JANX)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer. Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.
Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.35 | -3.26481257557 | 41.35 | 45.44 | 39.33 | 1322214 | 41.70687331 | CS |
| 4 | -13.22 | -24.8402856069 | 53.22 | 61.59 | 39.33 | 1190182 | 48.10228883 | CS |
| 12 | -13.5 | -25.2336448598 | 53.5 | 71.71 | 39.33 | 1178795 | 54.47582555 | CS |
| 26 | -4.08 | -9.25589836661 | 44.08 | 71.71 | 34.5125 | 850962 | 51.27209957 | CS |
| 52 | 30.64 | 327.35042735 | 9.36 | 71.71 | 7.79 | 853151 | 48.53459086 | CS |
| 156 | 25.6 | 177.777777778 | 14.4 | 71.71 | 5.65 | 345178 | 41.96023641 | CS |
| 260 | 6 | 17.6470588235 | 34 | 71.71 | 5.65 | 316460 | 40.24973904 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
